Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129238) titled 'Sinicization of the Inflammatory Bowel Disease Symptom Inventory Scale and its reliability and validity test' on Aug. 1.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Guabgzhou First People's Hospital
Condition:
Inflammatory Bowel Disease (IBD)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-10
Target Sample Size: none:752;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333940
Published by HT Digital Content Services with permission from Health Daily Digest....